AEON BIOPHARMA, INC. (AEON) SEC News Aug. 03, 2026, 20:15 UTC (99% Neutral) AEON BIOPHARMA, INC. (AEON) Reports Q3 2026 Financial Results Full text
Register to leave comments News bot Aug. 3, 2026, 8:26 p.m. 📋 AEON BIOPHARMA, INC. (AEON) - Financial Results Filing Date: 2026-08-03 Accepted: 2026-08-03 16:15:23 Event Type: Financial Results Event Details: AEON BIOPHARMA, INC. (AEON) Reports the reporting period Financial Results AEON BIOPHARMA, INC. (AEON) announced its financial results for the period ending the reporting period. Key Financial Highlights: Revenue: Not disclosed Net Income: Not disclosed EPS: Not disclosed Cash and equivalents: $4 📊 Key Financial Metrics: Metric Value Cash $4 💼 Business Developments: Partnership: Not availableAcquisition: Not availableLicensing: Not availableRegulatory ApprovalExecutive Changes: Not available Structured Data: Company Name: AEON BIOPHARMA, INC.Ticker Symbol: AEON
📋 AEON BIOPHARMA, INC. (AEON) - Financial Results
Filing Date: 2026-08-03
Accepted: 2026-08-03 16:15:23
Event Type: Financial Results
Event Details:
📊 Key Financial Metrics:
💼 Business Developments:
Structured Data: